# Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

> **NCT01533389** · PHASE4 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 114 (actual)

## Conditions studied

- Ureteral Stone

## Interventions

- **DRUG:** Silodosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01533389
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-08
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2013-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533389, "Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01533389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*